1-(2-(1-(2,4-dimethoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)ethylsulfonyl)-N-(4-methoxybenzyl)piperidin-4-amine

ID: ALA583084

Chembl Id: CHEMBL583084

PubChem CID: 45483240

Max Phase: Preclinical

Molecular Formula: C32H41N3O7S2

Molecular Weight: 643.83

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CNC2CCN(S(=O)(=O)CCC3CCc4ccccc4N3S(=O)(=O)c3ccc(OC)cc3OC)CC2)cc1

Standard InChI:  InChI=1S/C32H41N3O7S2/c1-40-28-12-8-24(9-13-28)23-33-26-16-19-34(20-17-26)43(36,37)21-18-27-11-10-25-6-4-5-7-30(25)35(27)44(38,39)32-15-14-29(41-2)22-31(32)42-3/h4-9,12-15,22,26-27,33H,10-11,16-21,23H2,1-3H3

Standard InChI Key:  RAHQNTORFBTXPI-UHFFFAOYSA-N

Associated Targets(Human)

AVPR1B Tclin Vasopressin V1b receptor (1301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Avpr1b Vasopressin V1b receptor (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 643.83Molecular Weight (Monoisotopic): 643.2386AlogP: 4.20#Rotatable Bonds: 12
Polar Surface Area: 114.48Molecular Species: BASEHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.42CX LogP: 3.08CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.31Np Likeness Score: -1.00

References

1. Scott JD, Miller MW, Li SW, Lin SI, Vaccaro HA, Hong L, Mullins DE, Guzzi M, Weinstein J, Hodgson RA, Varty GB, Stamford AW, Chan TY, McKittrick BA, Greenlee WJ, Priestley T, Parker EM..  (2009)  Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.,  19  (21): [PMID:19800231] [10.1016/j.bmcl.2009.09.050]

Source